ACAD
Acadia Pharmaceuticals Inc.
$25.60
-0.12%
-0.03
Notify me if price changes either direction
Buy ACAD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.4B
Enterprise value
3.6B
Trailing PE
11.597284
Forward PE
28.768982
PEG Ratio
-0.14174458222222
Enterprise to EBITDA
39.239
Enterprise to revenue
3.321
Price to book MRQ
3.5133653
Price to sales TTM
4.007099
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
1.1B
EBITDA
116.6M
Diluted EPS TTM
2.21
Total Cash (MRQ)
851.5M
Current ratio (MRQ)
3.587
Operating Cash Flow (TTM)
123.5M
ACAD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
